An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

被引:54
|
作者
Kunicki, TJ
Federici, AB
Salomon, DR
Koziol, JA
Head, SR
Mondala, TS
Chismar, JRD
Baronciani, L
Canciani, MT
Peake, AR
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, Div Biostat, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, Div Expt Hemostasis & Thrombosis, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA
[3] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA
[4] Maggiore Hosp, IRCCS, Dept Internal Med & Dermatol, Milan, Italy
[5] Univ Milan, I-20122 Milan, Italy
[6] Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England
关键词
D O I
10.1182/blood-2004-01-0349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease (VWD) type 1 is difficult to diagnose because of bleeding variability and low heritability of von Willebrand factor (VWF) levels. We compared a bleeding severity score and bleeding times to candidate gene haplotypes within pedigrees of 14 index cases, using a covariance components model for multivariate traits (Mendel: QTL Association). These pedigrees included 13 affected and 40 unaffected relatives, as defined by plasma ristocetin cofactor (VWF:RCo) levels. The bleeding severity score was derived from a detailed history. Donors were genotyped using a primer extension method, and 9 candidate genes were selected for analysis. VWF:RCo levels had the strongest influence on bleeding severity score and bleeding time. ITGA2 haplotype 2 (807C) and ITGA2B haplotype 1 (IIe(843)) were each associated With increased bleeding severity scores (P <.01 and P <.01, respectively). GP6 haplotype b (Pro(219)) was also associated with increased scores (P =.03) after adjustment for donor age. No association was ob-served with 6 other candidate genes, GP1BA, ITGB3, VWF, FGB, IL6, or TXA2R. Increased plasma VWF:Ag levels were associated with VWF haplotype 1 (-1793G; P =.02). These results establish that genetic differences in the adhesion receptor subunits alpha(2), alpha(IIb), and GPVI can influence the phenotype of VWD type 1. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2359 / 2367
页数:9
相关论文
共 50 条
  • [31] von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD
    Atiq, Ferdows
    Schutte, Lisette M.
    Looijen, Agnes E. M.
    Boender, Johan
    Cnossen, Marjon H.
    Eikenboom, Jeroen
    de Maat, Moniek P. M.
    Kruip, Marieke J. H. A.
    Leebeek, Frank W. G.
    BLOOD ADVANCES, 2019, 3 (24) : 4147 - 4154
  • [32] Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)
    Haberichter, Sandra L.
    Christopherson, Pamela A.
    Flood, Veronica H.
    Gill, Joan Cox
    Bellissimo, Daniel B.
    Friedman, Kenneth D.
    Montgomery, Robert R.
    BLOOD, 2013, 122 (21)
  • [33] Previously missed mutations in the MCMDM-1VWD type 1 von Willebrand disease study
    Alyami, N. H.
    Hampshire, D.
    Goudemand, J.
    Castaman, G.
    Federici, A. B.
    Cartwright, A.
    Peake, I. R.
    Goodeve, A. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 415 - 415
  • [34] Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management
    Siragusa, S.
    Malato, A.
    Lo Coco, L.
    Cigna, V.
    Saccullo, G.
    Abbene, I.
    Anastasio, R.
    Caramazza, D.
    Patti, R.
    Arcara, M.
    Di Vita, G.
    HAEMOPHILIA, 2008, 14 (01) : 150 - 152
  • [35] Seven novel candidate mutations in exon 27 and 28 of von Willebrand gene in patients with type 1, type 2 M and unclassified von Willebrand disease
    Enayat, MS
    Guilliatt, AM
    Surdhar, GK
    Jones, N
    Wilde, JT
    Chalmers, EA
    Tait, RC
    Strevens, MJ
    Williams, MD
    Hill, FGH
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 46 - 46
  • [36] Characterization of recessive severe type 1 and 3 von Willebrand disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD
    Michiels, Jan Jacques
    Berneman, Zwi
    Gadisseur, Alain
    van der Planken, Marc
    Schroyens, Wilfried
    van de Velde, Ann
    van Vliet, Huub
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (03) : 277 - 295
  • [37] Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
    Simon, D
    Bandinelli, E
    Roisenberg, I
    GENETICS AND MOLECULAR BIOLOGY, 2003, 26 (04) : 397 - 401
  • [38] A pregnant woman with von Willebrand disease (VWD) type 2b: Laboratory findings and peripartal bleeding management
    Holstein, K.
    Spath, B.
    Greinacher, A.
    Budde, U.
    Bokemeyer, C.
    Schneppenheim, R.
    Langer, F.
    HAEMOPHILIA, 2012, 18 : 196 - 196
  • [39] A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease
    Sood, S. L.
    James, A. H.
    Ragni, M. V.
    Shapiro, A. D.
    Witmer, C.
    Vega, R.
    Bolgiano, D.
    Konkle, B. A.
    HAEMOPHILIA, 2016, 22 (06) : E562 - E564
  • [40] Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study
    Eikenboom, J.
    Hilbert, L.
    Ribba, A. S.
    Hommais, A.
    Habart, D.
    Messenger, S.
    Al-Buhairan, A.
    Guilliatt, A.
    Lester, W.
    Mazurier, C.
    Meyer, D.
    Fressinaud, E.
    Budde, U.
    Will, K.
    Schneppenheim, R.
    Obser, T.
    Marggraf, O.
    Eckert, E.
    Castaman, G.
    Rodeghiero, F.
    Federici, A. B.
    Batlle, J.
    Goudemand, J.
    Ingerslev, J.
    Lethagen, S.
    Hill, F.
    Peake, I.
    Goodeve, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1304 - 1312